Riedl, M.; Witzmann, C.; Koch, M.; Lang, S.; Kerschbaum, M.; Baumann, F.; Krutsch, W.; Docheva, D.; Alt, V.; Pfeifer, C.
Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist. Int. J. Mol. Sci. 2020, 21, 1444.
https://doi.org/10.3390/ijms21041444
AMA Style
Riedl M, Witzmann C, Koch M, Lang S, Kerschbaum M, Baumann F, Krutsch W, Docheva D, Alt V, Pfeifer C.
Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist. International Journal of Molecular Sciences. 2020; 21(4):1444.
https://doi.org/10.3390/ijms21041444
Chicago/Turabian Style
Riedl, Moritz, Christina Witzmann, Matthias Koch, Siegmund Lang, Maximilian Kerschbaum, Florian Baumann, Werner Krutsch, Denitsa Docheva, Volker Alt, and Christian Pfeifer.
2020. "Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist" International Journal of Molecular Sciences 21, no. 4: 1444.
https://doi.org/10.3390/ijms21041444
APA Style
Riedl, M., Witzmann, C., Koch, M., Lang, S., Kerschbaum, M., Baumann, F., Krutsch, W., Docheva, D., Alt, V., & Pfeifer, C.
(2020). Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist. International Journal of Molecular Sciences, 21(4), 1444.
https://doi.org/10.3390/ijms21041444